Shuttle Pharmaceuticals Files 8-K: Director Changes & Compensation Updates
Ticker: SHPH · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, officer-compensation, governance
Related Tickers: SHPH
TL;DR
Shuttle Pharma (SHPH) filed an 8-K detailing director changes and compensation adjustments. Keep an eye on governance.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on March 12, 2025, reporting on the departure of a director, election of a new director, and changes in officer compensation. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directorship and officer compensation can indicate internal shifts that may affect company direction and stability.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
- March 11, 2025 (date) — Earliest event reported
- March 12, 2025 (date) — Filing date
FAQ
Who departed from the board of directors at Shuttle Pharmaceuticals?
The filing indicates the departure of a director, but the specific name is not provided in the provided text.
Was a new director elected to the board?
Yes, the filing explicitly states the election of a director.
What specific items are covered under 'Compensatory Arrangements of Certain Officers'?
The filing mentions this item, but the specific details of the compensatory arrangements are not included in the provided text.
What is the principal business address of Shuttle Pharmaceuticals?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the SEC file number for Shuttle Pharmaceuticals?
The SEC file number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).